Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicity
Dominantly inherited mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common causes of familial Parkinson's disease (PD) and LRRK2 polymorphisms are associated with increased risk for idiopathic PD. However, the molecular mechanisms by which these mutations cause PD remain uncerta...
Main Authors: | Xiaodong Ding, Sandeep K. Barodia, Lisha Ma, Matthew S. Goldberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-02-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996116302637 |
Similar Items
-
Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
by: Kaela Kelly, et al.
Published: (2020-08-01) -
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
by: Elisa Greggio, et al.
Published: (2006-08-01) -
“LRRK2: Autophagy and Lysosomal Activity”
by: Marta Madureira, et al.
Published: (2020-05-01) -
LRRK2 Phosphorylation, More Than an Epiphenomenon
by: Antoine Marchand, et al.
Published: (2020-06-01) -
LRRK2 Kinase Activity and Biology are Not Uniformly Predicted by its Autophosphorylation and Cellular Phosphorylation Site Status
by: April eReynolds, et al.
Published: (2014-06-01)